CLEAR LABELS Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3788 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 3788 To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES February 5, 2026 Mr. Scott of Florida (for himself, Mrs. Gillibrand, Mr. Tuberville, Mrs. Britt, and Mr. Johnson) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act'' or the ``CLEAR LABELS Act''. SEC. 2. REQUIRE DRUG LABELING TO INCLUDE ORIGINAL MANUFACTURER AND SUPPLY CHAIN INFORMATION. Section 502(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352(b)) is amended-- (1) by striking ``containing (1) the name and place of business of the manufacturer, packer, or distributor'' and inserting the following: ``containing-- ``(A) the name, place of business, and unique facility identifier of the manufacturer, packer, or distributor or a link, barcode, QR code, or other means to access a searchable electronic portal containing such information''; (2) in clause (A) (as so designated), by striking ``(2) an accurate'' and inserting the following: ``(B) an accurate''; (3) in clause (B) (as so designated), by striking ``count: Provided, That under clause (2) of this paragraph reasonable variations'' and inserting ``count,